MedTrace Logo

Testing the Re-Engineered Hospital Discharge

NCT00252057 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 749

Last updated 2017-03-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if the "Re-Engineered Discharge" will decrease rehospitalization rates and adverse events of patients leaving Boston Medical Center.

Conditions

Interventions

BEHAVIORAL

Re-Engineered Hospital Discharge

The "Re-engineered Hospital Discharge" (Project RED) intervention provides a set of 11 discrete, mutually reinforcing components provided by a Discharge Advocate and re-enforced by a telephone call after discharge by a clinical pharmacist.

Sponsors & Collaborators

  • Boston University

    lead OTHER

Principal Investigators

  • Brian Jack, MD · Boston Medical Center - Family Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2007-10-31
Completion
2007-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00252057 on ClinicalTrials.gov